A Study to Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 27, 2017

Primary Completion Date

November 23, 2017

Study Completion Date

November 23, 2017

Conditions
Renal ImpairmentHealthy Volunteer
Interventions
DRUG

Entinostat

HDAC (histone deacetylase) inhibitor

Trial Locations (3)

32809

Orlando Clinical Research Center, Orlando

33014

Clinical Pharmacology of Miami, Miami

37920

New Orleans Center for Clinical Research, Knoxville

Sponsors
All Listed Sponsors
lead

Syndax Pharmaceuticals

INDUSTRY

NCT03192111 - A Study to Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function | Biotech Hunter | Biotech Hunter